List of Tables
Table 1. Global Acute Liver Failure Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hepatocyte Transplantation
Table 3. Key Players of Assisted Liver Transplantation
Table 4. Key Players of Xenotransplantation
Table 5. Global Acute Liver Failure Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Acute Liver Failure Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Acute Liver Failure Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Acute Liver Failure Treatment Market Share by Region (2020-2025)
Table 9. Global Acute Liver Failure Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Acute Liver Failure Treatment Market Share by Region (2026-2031)
Table 11. Acute Liver Failure Treatment Market Trends
Table 12. Acute Liver Failure Treatment Market Drivers
Table 13. Acute Liver Failure Treatment Market Challenges
Table 14. Acute Liver Failure Treatment Market Restraints
Table 15. Global Acute Liver Failure Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Acute Liver Failure Treatment Market Share by Players (2020-2025)
Table 17. Global Top Acute Liver Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Liver Failure Treatment as of 2024)
Table 18. Ranking of Global Top Acute Liver Failure Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Acute Liver Failure Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Acute Liver Failure Treatment, Headquarters and Area Served
Table 21. Global Key Players of Acute Liver Failure Treatment, Product and Application
Table 22. Global Key Players of Acute Liver Failure Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Liver Failure Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Acute Liver Failure Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Acute Liver Failure Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Acute Liver Failure Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Acute Liver Failure Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Acute Liver Failure Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Acute Liver Failure Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Acute Liver Failure Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Acute Liver Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Acute Liver Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Acute Liver Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Acute Liver Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Acute Liver Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Acute Liver Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Acute Liver Failure Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Acute Liver Failure Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Acute Liver Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Acute Liver Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Acute Liver Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Acute Liver Failure Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Acute Liver Failure Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Acute Liver Failure Treatment Product
Table 50. Novartis AG Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Bayer AG Company Details
Table 53. Bayer AG Business Overview
Table 54. Bayer AG Acute Liver Failure Treatment Product
Table 55. Bayer AG Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 56. Bayer AG Recent Development
Table 57. Cardiorentis AG Company Details
Table 58. Cardiorentis AG Business Overview
Table 59. Cardiorentis AG Acute Liver Failure Treatment Product
Table 60. Cardiorentis AG Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 61. Cardiorentis AG Recent Development
Table 62. Cytokinetics, Inc. Company Details
Table 63. Cytokinetics, Inc. Business Overview
Table 64. Cytokinetics, Inc. Acute Liver Failure Treatment Product
Table 65. Cytokinetics, Inc. Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 66. Cytokinetics, Inc. Recent Development
Table 67. Orion Corporation Company Details
Table 68. Orion Corporation Business Overview
Table 69. Orion Corporation Acute Liver Failure Treatment Product
Table 70. Orion Corporation Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 71. Orion Corporation Recent Development
Table 72. Bristol-Myers Squibb Company Company Details
Table 73. Bristol-Myers Squibb Company Business Overview
Table 74. Bristol-Myers Squibb Company Acute Liver Failure Treatment Product
Table 75. Bristol-Myers Squibb Company Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 76. Bristol-Myers Squibb Company Recent Development
Table 77. PhaseBio Pharmaceuticals, InC Company Details
Table 78. PhaseBio Pharmaceuticals, InC Business Overview
Table 79. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Product
Table 80. PhaseBio Pharmaceuticals, InC Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 81. PhaseBio Pharmaceuticals, InC Recent Development
Table 82. Merck & Co Company Details
Table 83. Merck & Co Business Overview
Table 84. Merck & Co Acute Liver Failure Treatment Product
Table 85. Merck & Co Revenue in Acute Liver Failure Treatment Business (2020-2025) & (US$ Million)
Table 86. Merck & Co Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Acute Liver Failure Treatment Picture
Figure 2. Global Acute Liver Failure Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Acute Liver Failure Treatment Market Share by Type: 2024 VS 2031
Figure 4. Hepatocyte Transplantation Features
Figure 5. Assisted Liver Transplantation Features
Figure 6. Xenotransplantation Features
Figure 7. Global Acute Liver Failure Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Acute Liver Failure Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Liver Academic and Research Institutes Case Studies
Figure 12. Forensic Laboratories Case Studies
Figure 13. Acute Liver Failure Treatment Report Years Considered
Figure 14. Global Acute Liver Failure Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Acute Liver Failure Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Acute Liver Failure Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Acute Liver Failure Treatment Market Share by Players in 2024
Figure 18. Global Top Acute Liver Failure Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Liver Failure Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Acute Liver Failure Treatment Revenue in 2024
Figure 20. North America Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Acute Liver Failure Treatment Market Share by Country (2020-2031)
Figure 22. United States Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Acute Liver Failure Treatment Market Share by Country (2020-2031)
Figure 26. Germany Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Acute Liver Failure Treatment Market Share by Region (2020-2031)
Figure 34. China Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Acute Liver Failure Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Acute Liver Failure Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Acute Liver Failure Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Novartis AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 50. Bayer AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 51. Cardiorentis AG Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 52. Cytokinetics, Inc. Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 53. Orion Corporation Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 54. Bristol-Myers Squibb Company Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 55. PhaseBio Pharmaceuticals, InC Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 56. Merck & Co Revenue Growth Rate in Acute Liver Failure Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
